18 Worcester Business Journal | October 14, 2024 | wbjournal.com
FOR ANY SIZE BUSINESS
We have you covered
Simply Beter.
Member FDIC
Member DIF
Call one of our experienced commercial lenders at
800-649-3036 or email us at commercial@saversbank.com.
Notable venture capital deals
Ranked by funding amount, then transaction date
Company
Industry/
products and services
Funding amount/
type/
transaction date Select investors Head of company
1
Sionna Therapeutics
Natick
sionnatx.com
Life sciences
Cystic fibrosis treatments
$182,000,000
Series C
March 2024
Viking Global Investors, Q Healthcare Holdings, Perceptive Advisors,
Cystic Fibrosis Foundation
Mike Cloonan
president & CEO
2
Ascend Elements
Westborough
ascendelements.com
Manufacturing
Sustainable materials for
batteries
$162,000,000
Series D
Feb. 2024
Pario Ventures, Just Climate, Irongrey, Clearvision Ventures
Mike O'Kronley
CEO
3
Re:Build
Framingham
rebuildmanufacturing.com
Manufacturing
Integration of advanced
technologies with traditional
manufacturing processes
$120,000,000
Venture - series unknown
Aug. 2024
General Catalyst
Miles Arnone
CEO
4
Solid Biosciences
Marlborough
solidbio.com
Life sciences
Duchenne muscular
dystrophy treatments
$109,000,000
Post-IPO equity
Jan. 2024
Vestal Point Capital, RA Capital Management, Perceptive Advisors,
Janus Henderson Advisors, Invus
Bo Cumbo
president & CEO
5
Alzheon
Framingham
alzheon.com
Life sciences
Alzheimer's disease
treatments
$100,000,000
Series E
June 2024
Alerce Medical Technology Partners
Martin Toler
CEO
6
Aspen Aerogels
Northborough
aerogel.com
Energy
Performance and safety of
electric vehicles
$75,000,000
Post-IPO equity
Dec. 2023
Hood River Capital Management
Donald Young
CEO
7
AMSC
Ayer
amsc.com
Energy
Electric power infrastructure
$60,750,000
Post-IPO equity
Jan. 2024
Baird Capital
Daniel McGahn
CEO
8
Reprieve Cardiovascular
Milford
reprievecardio.com
Life sciences
Fluid removal for patients
with heart failure
$42,000,000
Series A
Feb. 2024
Sante Ventures, Lightstone Ventures, Genesis Capital, Deerfield
Management, Aboretum Ventures
Mark Pacyna
CEO
9
Variantyx
Framingham
variantyx.com
Life sciences
Treatments for rare genetic
disorders
$36,000,000
Series D
April 2024
Pitango VC, Peregrine Ventures, New Era Capital Partners, Bosch
Ventures
Haim Neerman
CEO
10
Stellaromics
Natick
stellaromics.com
Life sciences
3D in situ multi-omic
analysis technology
$25,000,000
Series A
Nov. 2023
Plaisance Capital Management
Todd Dickinson
CEO
11
Upstart Power
Southborough
upstartpower.com
Energy & manufacturing
Design, manufacture and
sales of solid oxide fuel cell
systems
$22,518,582
Series A
July 2024
Undisclosed
Paul Osenar
president & CEO
12
LiquidStack
Marlborough
Energy & electronics
Liquid cooling solutions
$20,000,000
Series B
Sept. 2024
Tiger Global Management
Joe Capes
CEO
13
ShopMy
Worcester
shopmy.us
Advertising & marketing
Platform for elite creators
and brands to collaborate
and promote products
$18,500,000
Series B
March 2024
Inspired Capital Partners, AlleyCorp
Harry Rein
CEO
14
Jetcool Technologies
Littleton
Manufacturing
Cooling systems for
electronics
$17,000,000
Series A
Oct. 2023
Schooner Capital, Raptor Group, In-Q-Tel, Bosch Ventures
Bernie Malouin
CEO
15
MeaCor
Ayer
meacor.com
Life sciences
Minimally invasive heart
valve repair solutions
$15,000,000
Series A
May 2024
Undisclosed
Toufic Azar
CEO & CTO
16
Veruna
Hopkinton
veruna.com
Insurance & technology
Insurance management
system
$10,000,000
Series B
Oct. 2023
The Institutes Knowledge Group, Keystone Insurers Group, Guidewire
Software, EMC Insurance, CoVerica, Berkeley Ventures
Jennifer Carroll
CEO
Source: Crunchbase. Notes: Deals completed from July 1, 2023 through Oct. 1, 2024 were considered for this list. N/A=not available.
-Compiled by: Stephanie R. Meagher, research@nebusinessmedia.com
F O C U S B A N K I N G & F I N A N C E
